SDIP Innovations
Sydney, Australia· Est.
Australian‑based med‑tech delivering low‑cost, bioresorbable bone implants with superior healing performance.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Estimated funding: $650K
AI Company Overview
Australian‑based med‑tech delivering low‑cost, bioresorbable bone implants with superior healing performance.
OrthopedicsBone Regeneration
Technology Platform
JAZBI™ is a bioresorbable polymer‑ceramic composite scaffold that provides adjustable mechanical strength, predictable resorption, and osteoconductive support for bone and tissue repair.
Opportunities
Cost‑effective, bioresorbable implants can capture market share in price‑sensitive health systems and expand into dental and spinal applications.
Risk Factors
Regulatory clearance, manufacturing scale‑up, and competition from established orthopedic device companies pose significant challenges.
Competitive Landscape
Competitors include Medtronic, Stryker, and niche bioresorbable firms; SDIP differentiates through lower cost, adjustable properties, and a natural healing environment.